High altitude cerebral edema: Difference between revisions
Ostermayer (talk | contribs) (→Source) |
Neil.m.young (talk | contribs) No edit summary |
||
| Line 34: | Line 34: | ||
[[High Altitude Medicine]] | [[High Altitude Medicine]] | ||
== | ==References== | ||
<references/> | <references/> | ||
[[Category:Environ]] | [[Category:Environ]] | ||
Revision as of 22:35, 23 February 2016
Background
- Also known as HACE
- Progressive neurologic deterioration in someone with AMS or HAPE (due to incr ICP)
- Almost never occurs at <8000ft
Clinical Features
- Altered mental status, ataxia, gait disturbance, stupor (most sensitive findings)
- Progresses to coma if untreated
- Headache, nausea, and vomiting are not always present
- Focal neuro deficits may be seen (3rd/6th CN palsies)
- Seizures are rare
Differential Diagnosis
High Altitude Illnesses
- Acute mountain sickness
- Chronic mountain sickness
- High altitude cerebral edema
- High altitude pulmonary edema
- High altitude peripheral edema
- High altitude retinopathy
- High altitude pharyngitis and bronchitis
- Ultraviolet keratitis
- Dehydration
- Exhaustion
- Hypoglycemia
- Hypothermia
- Hyponatremia
Treatment
- Immediate descent is the treatment of choice
- If descent not possible use combination of:
- Supplemental O2 (goal SpO2 90%)[1]
- Dexamethasone 8mg initially, then 4mg q6hr
- Acetazolamide 250 mg BID (better as ppx)
- Hyperbaric bag if available
Prevention
- Acetazolamide 125mg BID (250mg BID if greater than 100kg)
- Dexamethasone 4mg q6h PO or IV
See Also
References
- ↑ Hackett PH, Roach RC. High altitude cerebral edema. High Alt Med Biol 2004; 5:136-146.
